Some key regulatory genes and proteins were modulated, such as ATP7A, ABCG2, ABCC1 and ABCB1 in response to EC-synthetic retinoids, suggesting that their expression may be under the regulation of retinoid signaling pathways with a potential role in diminishing cancer resistance and carcinogenesis. The gene discussed is ABCB1; the disease is cancer.